Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 84
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01428661 | Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder | ||
| NCT02651714 | Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis | ||
| NCT01578057 | Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol | ||
| NCT02413918 | Iloperidone in Mixed States of Bipolar Disorder | ||
| NCT04353401 | WGS Analysis of COVID-19 Positive Patients | ||
| NCT04712734 | A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia | ||
| NCT06961968 | Randomized Withdrawal Study in Patients With Schizophrenia | ||
| NCT03772340 | Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
| NCT06836557 | Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis | ||
| NCT04800237 | Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety | ||
| NCT06804603 | A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use | ||
| NCT01402076 | A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects | ||
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | ||
| NCT05366855 | Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP | ||
| NCT04127058 | Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia | ||
| NCT01291511 | Relapse Prevention Study in Patients With Schizophrenia | ||
| NCT06830044 | Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder | ||
| NCT04622345 | Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies | ||
| NCT04652882 | Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) | ||
| NCT01429116 | Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception | ||
| NCT06701396 | Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant | ||
| NCT05903924 | Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness | ||
| NCT04474990 | Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis | ||
| NCT02621385 | Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects | ||
| NCT01271387 | Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment | ||
| NCT07446439 | A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use | ||
| NCT04327661 | Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
| NCT01637636 | Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin. | ||
| NCT05922995 | The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD) | ||
| NCT04697056 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis | ||
| NCT04856917 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris | ||
| NCT01195558 | Patient Registry of Blind Subjects With Sleep-related Problems | ||
| NCT01526746 | Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function | ||
| NCT02231008 | Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | ||
| NCT01348100 | Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients | ||
| NCT00548340 | VEC-162 Study in Adult Patients With Primary Insomnia | ||
| NCT06953869 | Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia | ||
| NCT06296966 | A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye | ||
| NCT05648591 | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | ||
| NCT06494397 | Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions | ||
| NCT03838926 | Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies | ||
| NCT07223632 | Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient | ||
| NCT06138613 | Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness | ||
| NCT06323655 | Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects | ||
| NCT01218789 | Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception | ||
| NCT04028492 | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis | ||
| NCT04819776 | Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder | ||
| NCT07362017 | Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis | ||
| NCT07065773 | Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis | ||
| NCT04140695 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) |
